Attributes | Values |
---|
rdf:type
| |
description
| - wetenschappelijk artikel (nl)
- im April 2020 veröffentlichter wissenschaftlicher Artikel (de)
- scientific article published on 03 April 2020 (en)
- наукова стаття, опублікована 3 квітня 2020 (uk)
- artículu científicu espublizáu'l 3 de abril de 2020 (ast)
|
publication date
| |
publication date
| |
cites work
| |
cites work
| |
author name string
| |
author name string
| - CDC COVID-19 Response Team
|
rdfs:label
| - Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020 (en)
- Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020 (nl)
- Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020 (ast)
|
skos:prefLabel
| - Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020 (en)
- Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020 (nl)
- Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020 (ast)
|
name
| - Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020 (en)
- Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020 (nl)
- Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020 (ast)
|
title
| |
title
| - Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 - United States, February 12-March 28, 2020 (en)
|
page(s)
| |
page(s)
| |
instance of
| |
instance of
| |
main subject
| |
main subject
| |
PubMed ID
| |
PubMed ID
| |
PubMed ID
| |
published in
| |
published in
| |
issue
| |
volume
| |
issue
| |
volume
| |
DOI
| |
DOI
| |
DOI
| |
Dimensions Publication ID
| |
Dimensions Publication ID
| |
PMCID
| |
PMCID
| |
COVIDWHO ID
| |
COVIDWHO ID
| |
is about
of | |
is cites work
of | - Racial Disparities in COVID-19 Hospitalization and In-hospital Mortality at the Height of the New York City Pandemic
- Continuous hydroxychloroquine or colchicine therapy does not prevent infection with SARS-CoV-2: Insights from a large healthcare database analysis
- Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study
- Clinical Characteristics and Outcome in Patients with Combined Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State Associated with COVID-19: A Retrospective, Hospital-Based Observational Case Series
- Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State
- Extrapulmonary manifestations of COVID-19
- The epidemiological burden of and overall distribution of chronic comorbidities in coronavirus disease-2019 among 202,005 infected patients: evidence from a systematic review and meta-analysis
- Corticosteroids, but not TNF Antagonists, are Associated with Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results from an International Registry
- The Perfect Storm: Coronavirus (Covid-19) Pandemic Meets Overfat Pandemic
- Cardiovascular manifestations and treatment considerations in covid-19
- Why is SARS-CoV-2 infection milder among children?
- Head and neck cancer: A high-risk population for COVID-19
- Editorial: Nicotine and SARS-CoV-2: COVID-19 may be a disease of the nicotinic cholinergic system
- Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option?
- Current smoking, former smoking, and adverse outcome among hospitalized COVID-19 patients: a systematic review and meta-analysis
- SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract
- Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis
- COVID-19: counter-intuitive data on smoking prevalence and therapeutic implications for nicotine
- Determinants of COVID-19 disease severity in patients with cancer
- A tale of two pandemics: How will COVID-19 and global trends in physical inactivity and sedentary behavior affect one another?
- Assessment of SARS-CoV-2 Infection Prevalence in Homeless Shelters - Four U.S. Cities, March 27-April 15, 2020
- Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study
- Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs
- Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform
- The prevalence and influencing factors in anxiety in medical workers fighting COVID-19 in China: A cross-sectional survey
- Anti-cancer therapy and clinical trial considerations for gynecologic oncology patients during the COVID-19 pandemic crisis
- Reply to the letter of Singh and Singh in response to the article: "Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis" (Kumar et al.).
- Robust ACE2 protein expression localizes to the motile cilia of the respiratory tract epithelia and is not increased by ACE inhibitors or angiotensin receptor blockers
- Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations
- Prevalence of Comorbidities Among Individuals With COVID-19: A Rapid Review of current Literature
- CLL and COVID-19 at the Hospital Clinic of Barcelona: an interim report
- Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer
- COVID-19 in diabetic patients: related risks and specifics of management
- In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication
- COVID-19 and Diabetes: A Collision and Collusion of Two Diseases
- Cardio-oncology Care in the Time of COVID-19 and the Role of Telehealth
- COVID-19 Outbreak Among Three Affiliated Homeless Service Sites - King County, Washington, 2020
- The Effect of Smoking on COVID-19 Symptom Severity: Systematic Review and Meta-Analysis
- COVID-19: risk accumulation among biologically and socially vulnerable older populations
- [COVID-19 and cardiovascular and kidney disease: Where are we? Where are we going?]
- Coronavirus and Obesity: Could Insulin Resistance Mediate the Severity of Covid-19 Infection?
- Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
|